Results 1 to 10 of about 74,023 (261)
Some of the next articles are maybe not open access.
Special Issue: HPV and HPV Vaccines [PDF]
Viruses, 2022 Our fundamental understanding of papillomaviruses and their interactions with their host, including their role in cancer and how the immune system responds to them, has made the elimination of cervical cancer a realistic global health goal [...]
openaire +3 more sources
Diagnostics, 2023 Background: Persistent infection with human papillomavirus (HPV) can lead to cervical cancer (CxCa). During the progression to CxCa, the expression of HPV oncogenes E6 and E7 is upregulated. In turn, cellular proteins such as p16INK4a are also modulated.
Anna Sophie Skof +5 more
doaj +1 more source
Enhancement of specific T-lymphocyte responses by monocyte-derived dendritic cells pulsed with E2 protein of human papillomavirus 16 and human p16INK4A [PDF]
PeerJ, 2020 Introduction Prophylactic vaccines are already available for prevention of human papillomavirus (HPV) infection. However, we still await development of therapeutic vaccines with high efficiency for stimulating specific T lymphocytes to clear HPV ...
Nuchsupha Sunthamala +8 more
doaj +2 more sources
TLR9 and Glioma: Friends or Foes?
Cells, 2022 Toll-like receptor 9 (TLR9) is an intracellular innate immunity receptor that plays a vital role in chronic inflammation and in recognizing pathogenic and self-DNA in immune complexes. This activation of intracellular signaling leads to the transcription
Emna Fehri +4 more
doaj +1 more source
Preventive Medicine Reports, 2023 The COVID-19 pandemic has exacerbated the existing challenges to achieving the WHO target of eliminating cervical cancer as a public health problem by working towards the target of fewer than four cases per 100 000 women.
Jieying Lee +4 more
doaj +1 more source